Introduction
============

Though 99.9% of the genome between humans is identical, millions of variant sites exist in different frequencies between populations, which leads to differences in gene expression and other complex traits ([@ref-11]). Since most GWAS have been conducted in European cohorts and most databases are built upon European data, the results may not accurately extrapolate to other global populations, which could lead to disparity within medicine ([@ref-12]). This discrepancy is alarming considering urgent health issues worldwide, such as obesity and cardiovascular disease. Lipid levels as a complex trait are increasingly concerning due to the growing global rate of obesity caused by the increasing availability of high-fat foods and rapid urbanization ([@ref-20]). Decreased high density lipoprotein (HDL) cholesterol levels and increased low density lipoprotein (LDL) cholesterol and triglyceride (TRIG) levels are associated with cardiovascular disease, the leading cause of death in the United States ([@ref-23]). Studies such as the Global Lipids Genetic Consortium (GLGC) acquire information predominantly from Europeans, but lack information from other populations ([@ref-15]; [@ref-51]). We aim to help remedy this issue by studying lipid traits in diverse populations. We chose two populations with lipid phenotypes available to study from the database of Genotypes and Phenotypes: Yoruba in Ibadan, Nigeria, (Yoruba) and Filipino in Cebu, Philippines (Cebu) ([@ref-26]; [@ref-1]; [@ref-53]).

At the time of our study, one of the largest available cholesterol SNP meta-analyses is the GLGC ([@ref-51]). The cohort in that study consists of 188,577 European-ancestry individuals and 7,898 non-European-ancestry individuals. One hundred fifty-seven loci were found to be significantly associated with total cholesterol (CHOL), HDL, TRIG, or LDL levels, and they conducted further gene set enrichment analysis with MAGENTA ([@ref-7]). However, gene-level association studies that integrate transcriptome data, like PrediXcan and TWAS, were not performed ([@ref-21]; [@ref-25]). Summary statistics from GLGC were used as a replication and base set in our analyses of the Yoruba and Cebu cohorts.

Both the Cebu and Yoruba cohorts have been used in genetic studies of lipids previously ([@ref-26]; [@ref-53]). These studies, both using the same data we study here, focused on *APOE*, a well-known gene that is associated with lipid levels and Alzheimer's disease ([@ref-37]). Previously, SNP-level GWAS in the Cebu and other East Asian cohorts attributed [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) as affecting function of *APOA5*, which is located 571 bases upstream ([@ref-53]; [@ref-31]; [@ref-45]). Beyond the *APOE* candidate gene study, no full GWAS has been conducted in the Yoruba cohort.

In this study, we performed a genome wide association study (GWAS) in each population using linear mixed modeling ([@ref-59]) and a conditional and joint analysis ([@ref-55]). Subsequently, we calculated the genetic correlation for each lipid trait between the populations at the SNP-level using bivariate REML analysis ([@ref-56]). We also used cross-population empirical Bayes (XPEB) modeling to improve power to detect SNPs with similar effects as previously found in larger European meta-analyses ([@ref-15]). Finally, we used the transcriptome-informed method PrediXcan to implicate genes in CHOL, HDL, LDL, and TRIG ([@ref-21]). Using our data and those from previous European studies, we confirm previously known loci and implicate new loci through the mechanism of gene expression regulation in Filipinos ([@ref-51]). Our gene-based association study for triglyceride levels in the Cebu cohort suggests that [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) may affect the expression of *BACE1* and *SIDT2* rather than that of *APOA5*.

Materials and Methods
=====================

Cohorts
-------

We obtained data from both cohorts through the database of Genotypes and Phenotypes with Institutional Review Board approval ([@ref-33]) ([Table 1](#table-1){ref-type="table"}). Yoruba consists of 1,251 adults of Yoruba ethnicity age 73 to 103 years old, living in Ibadan, Nigeria in 2001, who were originally studied in the Indianapolis Ibadan Epidemiological Study of Dementia ([@ref-39]). The Cebu population consists of 1,799 Filipino mothers, who gave birth between May 1, 1983 and April 30, 1984 in the metropolitan area of Cebu, Philippines. This cohort was originally studied in the Cebu Longitudinal Health and Nutrition Survey ([@ref-1]), and at the time of data collection in 2005, the mothers were age 34 to 70. The Yoruba cohort was genotyped with the Illumina HumanOmni2.5 array and the Cebu cohort was genotyped with the Affymetrix Genomewide Human SNP Array 5.0. Both cohorts had CHOL, HDL, LDL, and TRIG levels measured after fasting (mg/dL) and we subsequently rank normalized each trait ([@ref-5]) ([Table S2](#supp-2){ref-type="supplementary-material"}). See <https://github.com/aandaleon/px_chol> for all scripts used in our analyses.
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###### Data analyzed.
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                              Yoruba                                                                      Cebu
  --------------------------- --------------------------------------------------------------------------- ---------------------------------------------------------------------------
  Accession number            [phs000378.v1.p1](https://www.ncbi.nlm.nih.gov/gap/?term=phs000378.v1.p1)   [phs000523.v1.p1](https://www.ncbi.nlm.nih.gov/gap/?term=phs000523.v1.p1)
  Type of genotyping          Whole genome genotyping                                                     Whole genome genotyping
  Source platform             Illumina, HumanOmni2.5                                                      Affymetrix, Genomewide Human SNP Array 5.0
  Pre-QC SNPs                 2,443,179                                                                   440,792
  Pre-QC individuals          1,251                                                                       1,799
  Post-QC SNPs                1,522,836                                                                   369,185
  Post-QC individuals         1,017                                                                       1,765
  Post-imputation GWAS SNPs   12,553,142                                                                  4,496,603

Summary statistics from the Global Lipids Genetic Consortium meta-analysis ([@ref-51]) were downloaded from <http://csg.sph.umich.edu/abecasis/public/lipids2013/>. Though the offspring of the Cebu cohort are included in the GLGC cohort, they form a small portion of the dataset (1,771/188,577) and thus do not drive the signal for the entire dataset.

Quality control
---------------

We performed quality control on the genotypes in these cohorts with PLINK following a standard quality control pipeline ([@ref-48]; [@ref-42]). Starting with the dbGaP PLINK binary files, we removed SNPs with call rates \< 99% in the individual populations. Subsequently, SMARTPCA within Eigensoft was used to map individuals on their first 10 principal components, and individuals with excess (±5 standard deviations) from the population mean on the first two components were removed ([@ref-40]) ([Figs. S1](#supp-5){ref-type="supplementary-material"} and [S2](#supp-6){ref-type="supplementary-material"}). This was followed by removing individuals with excess heterozygosity (±3 standard deviations), leaving the Yoruba cohort with 1,017 individuals with genotype and lipid phenotype data, including 1,522,836 SNPs. The Cebu cohort retained 1,757 individuals with genotype and lipid phenotype data, including 369,185 SNPs. Both cohorts were mapped to hg19, which included performing a liftover in the Cebu cohort from hg18 to hg19. We used an imputation preparation tool on the Cebu cohort available at [http://www.well.ox.ac.uk/ wrayner/tools/](http://www.well.ox.ac.uk/ wrayner/tools/) that adjusted the data by matching the strand, alleles, position, ref/alt assignments, and frequency differences to the 1000G reference panel.

Imputation
----------

Yoruba SNPs were imputed on the Sanger Imputation Server with EAGLE2 and PBWT using the African Genomes Reference Panel to improve genome coverage ([@ref-17]; [@ref-18]; [@ref-35]). We imputed the Cebu SNPs using the Michigan Imputation Server with the 1000 Genomes phase 3 reference panel and EAGLE2 ([@ref-6]; [@ref-16]; [@ref-30]). The output from the imputation was filtered to remove SNPs with *R*^2^ \< 0.8 and minor allele frequency \<0.01, leaving 12,553,142 SNPs for analysis in Yoruba and 4,496,603 SNPs for analysis in Cebu.

SNP-level genome-wide association study
---------------------------------------

The imputed genotype dosages were used in a genome-wide association study performed with Genome-Wide Efficient Mixed Model Analysis (GEMMA) software using a univariate linear mixed model for each of the four phenotypes ([@ref-59]). SNPs with *P* \< 5 × 10^−8^ using the Wald test were considered genome-wide significant. The top SNPs from the GEMMA analysis were plotted using LocusZoom to depict their proximity to various genes ([@ref-41]). For each phenotype tested, we also used GEMMA to obtain the percent variance explained (PVE) by all the SNPs, i.e., the "chip heritability" ([@ref-59]). Conditional and joint analyses were then performed using GCTA-COJO ([@ref-56]; [@ref-55]) to identify the lead SNP or SNPs at each locus.

Comparison of populations
-------------------------

Both populations' GEMMA results and summary statistics from GLGC ([@ref-51]) were used in a cross-population empirical Bayes model (XPEB) to compute false discovery rates for each SNP, with significance declared at FDR \< 0.05. This model improves efficiency in GWAS by incorporating relevant results from larger (ex. GLGC) GWAS only when there are similar effect sizes between populations ([@ref-15]). Sample sizes in the GLGC results ranged from 50,000 to 187,365 depending on the SNP. Because XPEB assumes similar sample size in the base population across SNPs, we ran XPEB using only the SNPs with sample size between 80,000 and 95,000 in GLGC, which left us with 4,454,201 markers for each phenotype. SNP-level comparisons between populations were performed using Genome-wide Complex Trait Analysis (GCTA) software ([@ref-56]). We performed a bivariate restricted maximum likelihood (REML) analysis to estimate the genetic correlation between the Cebu and Yoruba cohorts for each phenotype ([@ref-28]).

Gene-based association study
----------------------------

PrediXcan, the gene-level association study, was performed using models built with cis-expression quantitative trait loci results from the Genotype-Tissue Expression Project (GTEx) ([@ref-3]; [@ref-49]; [@ref-9]). GTEx models (GTEx-V6p-HapMap-2016-09-08.tar.gz) were downloaded from PredictDB at <http://predictdb.hakyimlab.org/>. Significance for each tissue was determined as FDR \<0.1 across all testable genes in all tissues (*N* = 198,970). In total, 44 GTEx models were tested in both cohorts ([Table 2](#table-2){ref-type="table"}). Predicted expression levels were obtained and tested for association with the lipid phenotypes using PrediXcan software ([@ref-21]). Significant genes were further plotted using ggplot to depict the predicted gene expression against the observed phenotype ([@ref-50]). For the replication cohort, GLGC, Summary-PrediXcan ([@ref-9]) was used because only summary statistics were available.
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###### The number of genes tested in PrediXcan using expression prediction models built in GTEx Project tissues.

Genes tested had a cross-validated prediction performance *R*^2^ \> 0.01.
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  Tissue model                                Tissue abbreviation   Genes tested   Tissue model                          Tissue abbreviation   Genes tested
  ------------------------------------------- --------------------- -------------- ------------------------------------- --------------------- --------------
  Adipose---Subcutaneous                      ADPSBQ                7,254          Esophagus---Mucosa                    ESPMCS                7,710
  Adipose---Visceral (Omentum)                ADPVSC                4,447          Esophagus---Muscularis                ESPMSL                6,338
  Adrenal Gland                               ADRNLG                3,785          Heart---Atrial Appendage              HRTAA                 4,450
  Artery---Aorta                              ARTAORT               5,943          Heart---Left Ventricle                HRTLV                 4,718
  Artery---Coronary                           ARTCRN                3,141          Liver                                 LIVER                 2,502
  Artery---Tibial                             ARTTBL                7,074          Lung                                  LUNG                  6,448
  Brain---Anterior cingulate cortex (BA24)    BRNACC                2,430          Muscle---Skeletal                     MSCLSK                6,520
  Brain---Caudate (basal ganglia)             BRNCDT                3,325          Nerve---Tibial                        NERVET                8,016
  Brain---Cerebellar hemisphere               BRNCHB                4,077          Ovary                                 OVARY                 2,673
  Brain---Cerebellum                          BRNCHA                5,066          Pancreas                              PNCREAS               4,603
  Brain---Cortex                              BRNCTXA               3,334          Pituitary                             PTTARY                3,094
  Brain---Frontal Cortex (BA9)                BRNCTXB               3,138          Prostate                              PRSTTE                2,491
  Brain---Hippocampus                         BRNHPP                2,508          Skin---Not Sun Exposed (Suprapubic)   SKINNS                5,471
  Brain---Hypothalamus                        BRNHPT                2,290          Skin---Sun Exposed (Lower leg)        SKINS                 7,665
  Brain---Nucleus accumbens (basal ganglia)   BRNNCC                2,984          Small Intestine---Terminal Ileum      SNTTRM                2,515
  Brain---Putamen (basal ganglia)             BRNPTM                2,621          Spleen                                SPLEEN                3,602
  Breast---Mammary Tissue                     BREAST                4,473          Stomach                               STMACH                4,035
  Cells---EBV-transformed lymphocytes         LCL                   3,441          Testis                                TESTIS                7,002
  Cells---Transformed fibroblasts             FIBRBLS               7,543          Thyroid                               THYROID               7,853
  Colon---Sigmoid                             CLNSGM                3,619          Uterus                                UTERUS                2,058
  Colon---Transverse                          CLNTRN                4,729          Vagina                                VAGINA                1,939
  Esophagus---Gastroesophageal Junction       ESPGEJ                3,457          Whole Blood                           WHLBLD                6,588

Backward elimination modeling
-----------------------------

Because our PrediXcan analysis showed multiple genes associated with TRIG at the 11q23.3 locus in Cebu, we conducted a backward elimination analysis to determine the lead gene or genes. We used the R *lm* function to build all multiple linear regression models. The starting model included predicted expression terms for all genes with [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) or a linked SNP (*r*^2^ \> 0.6) in its predictive model and the absolute value of the marginal *t*-statistic greater than 3. The term with the highest *P*-value was eliminated and the model rerun until only terms with *P* \< 0.05 remained in the model.

Results
=======

Yoruba SNP-level GWAS
---------------------

We sought to better understand the genetic architecture of lipid traits within and across populations. In the Yoruba cohort from Ibadan, Nigeria, which included 1,017 individuals and 12,553,142 SNPs, we conducted SNP-level GWAS for four lipid traits CHOL, HDL, LDL, and TRIG. For each lipid trait, we used a univariate linear mixed model, which accounts for relatedness within the populations ([@ref-59]). This was especially important because one-third of the Yoruba cohort is related to at least one other member (proportion identity by descent \> 0.125). Across the four phenotypes, five SNPs surpassed the genome-wide significance threshold of *P* \< 5 × 10^−8^ at two loci ([Fig. 1](#fig-1){ref-type="fig"}). Conditional and joint analysis ([@ref-56]; [@ref-55]) did not reveal additional associated SNPs at these two loci and the top hits are shown in [Table 3](#table-3){ref-type="table"}. [rs34065661](http://www.ncbi.nlm.nih.gov/snp/?term=rs34065661) is on chromosome 16q13 within an intron of *CETP* and [rs1065853](http://www.ncbi.nlm.nih.gov/snp/?term=rs1065853) is on chromosome 19q13.32 near *APOE* ([Fig. 1](#fig-1){ref-type="fig"}). Both *CETP* and *APOE* are well-known and well-studied lipid genes ([@ref-13]; [@ref-43]).

![LocusZoom plots of the most significant SNPs in (A) HDL ([rs34065661](http://www.ncbi.nlm.nih.gov/snp/?term=rs34065661)) and (B) LDL ([rs1065853](http://www.ncbi.nlm.nih.gov/snp/?term=rs1065853)) in Yoruba.\
The color of each dot represents the SNP's linkage disequilibrium *r*^2^ with the labeled SNP in the 1000 Genomes African populations.](peerj-06-4314-g001){#fig-1}
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###### SNP-level GWAS results in the Yoruba (Y) and Cebu (C) populations.

Shown are SNPs that reach genome-wide significance after conditional and joint analysis ([@ref-56]; [@ref-55]).
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  Pop.   Pheno.   Chr.   Position    SNP ids                                                          Nearest gene   Non- effect allele   Effect allele   EAF     Marginal Beta   Marginal P      Joint Beta   Joint P
  ------ -------- ------ ----------- ---------------------------------------------------------------- -------------- -------------------- --------------- ------- --------------- --------------- ------------ ---------------
  Y      HDL      16     56995935    [rs34065661](http://www.ncbi.nlm.nih.gov/snp/?term=rs34065661)   *CETP*         C                    G               0.093   0.468           9.0 × 10^−10^   0.468        8.7 × 10^−10^
  Y      LDL      19     45413233    [rs1065853](http://www.ncbi.nlm.nih.gov/snp/?term=rs1065853)     *APOE*         G                    T               0.113   −0.405          6.6 × 10^−9^    −0.405       6.4 × 10^−9^
  C      TRIG     11     116663707   [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799)       *APOA5*        A                    G               0.245   0.342           2.7 × 10^−16^   0.342        2.5 × 10^−18^
  C      TRIG     2      27731212    [rs3817588](http://www.ncbi.nlm.nih.gov/snp/?term=rs3817588)     *GCKR*         T                    C               0.309   −0.202          2.6 × 10^−7^    −0.202       2.1 × 10^−8^

Cebu SNP-level GWAS
-------------------

We performed SNP-level GWAS for the same four lipid phenotypes in 1,765 individuals from Cebu, Philippines, using 4.5 million imputed SNPs (see Methods). No SNPs met genome-wide significance for the CHOL, HDL, and LDL phenotypes. However, 44 SNPs were genome-wide significant (*P* \< 5 × 10^−8^) for TRIG and all grouped on chromosome 11q23.3 ([Fig. 2](#fig-2){ref-type="fig"}), a locus that includes various lipid genes such as *APOA1* and *APOA4*. The most significant SNP in this group is [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799), with a marginal *P* = 2.7 × 10^−16^. It is located 571 base pairs upstream of *APOA5*, and has been previously associated with cholesterol traits in Asian populations, possibly due to its high minor allele frequency within Asian populations, with MAF for minor allele G at 0.245 in 1000 Genomes EAS compared to 0.083 in EUR ([@ref-34]) ([Fig. 3](#fig-3){ref-type="fig"}). Conditional and joint analysis ([@ref-56]; [@ref-55]) did not reveal additional associated SNPs at the 11q23.3 locus, but did reveal an additional genome-wide significant SNP on chromosome 2 in the *GCKR* gene ([Table 3](#table-3){ref-type="table"}). As a positive control, we compared the results from the previous Cebu GWAS ([@ref-53]) and our GWAS and obtained largely the same significant results ([Table S1](#supp-1){ref-type="supplementary-material"}).

![The top Cebu GWAS signal, [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799), which associated with TRIG levels is 571 bp upstream of *APOA5*.\
The color of each dot represents the SNP's linkage disequilibrium *r*^2^ with [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) in the 1000 Genomes East Asian populations.](peerj-06-4314-g002){#fig-2}

![Allele frequencies of TRIG associated SNP and driver of predicted expression models in multiple genes, [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799), in 1000 Genome populations.\
Figure generated with the Geography of Genetic Variants Browser ([@ref-34]).](peerj-06-4314-g003){#fig-3}

Integrating larger European study results into Yoruba and Cebu SNP-level GWAS
-----------------------------------------------------------------------------

The overlapping genetic architecture between populations for most traits is likely nonzero, but not 100% either due to differences in allele frequencies, effect sizes, and linkage disequilibrium patterns. Currently, European GWAS often have sample sizes 100 times larger than non-European studies. However, studies in diverse populations are growing ([@ref-45]; [@ref-52]). Traditional meta-analysis methods give the most weight to the GWAS with the largest sample size. Therefore, meta-analyses combining populations by traditional methods would be driven by the European results, drowning out any additional signal. The cross-population empirical Bayes (XPEB) method is designed to boost signal in a target (small, usually non-European) population whenever the base (large, usually European) population shares genetic architecture, but does not generate false positives when the signal is only present in the base population ([@ref-15]).

We used XPEB to improve power for mapping lipid traits in the Yoruba and Cebu cohorts by integrating results from the base population GLGC, a large lipid meta-analysis of European individuals ([@ref-51]). In XPEB, we input the SNPs and *P*-values from both our target GWAS (Yoruba or Cebu) and the base European GWAS. The output includes a population-wide estimate of the degree of genetic architecture overlap, *κ*~1~, and a new false discovery rate (FDR) for each individual SNP in common between the base and target GWAS.

In the Yoruba population, we found associated loci (FDR \< 0.05) using XPEB for the CHOL, HDL, and LDL phenotypes ([Table S3](#supp-3){ref-type="supplementary-material"}). These results reflect the estimated architecture overlap with GLGC, where *κ*~1~ was 0.65 for CHOL, 0.51 for HDL, 0.9 for LDL, and 0 for TRIG. The *CETP* locus, which was also significant in the Yoruba-only HDL GWAS was the most significant result in the XPEB analysis. In addition, several other previously implicated genes were significant in the XPEB analysis, including *LDLR* for CHOL and *PCSK9*, *LPA*, and *SMARCA4* for LDL ([@ref-53]; [@ref-51]; [@ref-46]).

In Cebu, CHOL, TRIG, and LDL each had *κ*~1~ = 0.90, while HDL had *κ*1 = 0.64. Tens or hundreds of SNPs had FDR \< 0.05 for each phenotype, including those found in the Cebu-only GWAS ([Table 3](#table-3){ref-type="table"}). Additional significant SNPs located within or near other well-known, previously studied lipid genes included *CETP* and *LIPC* in HDL; *PLCG1* and *TOP1* in LDL; and *APOA5* and *BUD13* in TRIG ([@ref-4]; [@ref-45]; [@ref-53]; [@ref-57]; [@ref-27]) ([Table S4](#supp-4){ref-type="supplementary-material"}).

Heritability
------------

As part of our GWAS study, we also estimated the percent variance explained (PVE) by all SNPs tested, i.e., "chip heritability", using GEMMA and conducted further genetic correlation analysis using GCTA ([@ref-56]; [@ref-59]). By estimating heritability, we can help determine which portion of our phenotype is not explained through our analyses and is influenced by other factors, such as diet.

In the Yoruba cohort, no PVE estimate was significantly different than zero. All PVE estimates for Yoruba were low when compared to variance component studies in a Finnish cohort of 5,123 individuals ([@ref-44]; [@ref-58]). Unlike in Yoruba, PVE estimates for two phenotypes, HDL and TRIG, within the Cebu were significantly different than zero and closer to the Finnish estimates ([Table 4](#table-4){ref-type="table"}).
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###### Percent variance explained (PVE) and standard error as estimated in GEMMA for each trait compared.
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         Yoruba (*n* = 1,017)   Cebu (*n* = 1,765)   European (*n* = 5,123)[^a^](#table-4fn1){ref-type="fn"}
  ------ ---------------------- -------------------- ---------------------------------------------------------
  CHOL   0.040 ± 0.061          0.067 ± 0.093        0.29 ± 0.043
  HDL    0.013 ± 0.037          0.217 ± 0.091        0.34 ± 0.043
  TRIG   0.049 ± 0.110          0.140 ± 0.103        0.38 ± 0.041
  LDL    0.029 ± 0.046          0 ± 0.096            0.19 ± 0.047

**Notes.**

[@ref-44] and [@ref-58].

We attempted to estimate the genetic correlation between all SNPs in the Cebu and Yoruba populations using bivariate REML analysis as implemented in GCTA ([@ref-28]). The only phenotype that converged was TRIG, with an estimated correlation of 0.644 ± 0.65, indicating there is shared architecture between the populations. However, the small sample sizes available in our study do not offer enough power to reliably estimate heritability and genetic correlation as indicated by the large standard errors.

Yoruba gene-based association study
-----------------------------------

While many GWAS have been performed on lipid traits, most of the significant SNPs found fall outside of protein coding regions and thus their mechanisms of action are not immediately apparent. PrediXcan is a gene-level association method that incorporates functional data on potential regulatory elements to provide mechanistic directionality for association of a gene with a phenotype ([@ref-21]). PrediXcan uses gene expression prediction models built from genome-transcriptome datasets such as the Genotype-Tissue Expression (GTEx) Project to predict gene expression from genotype and then tests the predicted expression levels for association with with trait of interest ([@ref-3]). We applied PrediXcan to our SNP-level GWAS results using models built in 44 GTEx tissues ([@ref-9]) ([Table 2](#table-2){ref-type="table"}).

For each tissue, we declared associations significant if FDR \<0.1, across all genes and tissues tested, to adjust for multiple testing. Of the four phenotypes for this cohort and 44 tissues with models available, one gene, *PAX6*, surpassed the significance threshold. *PAX6* was not significant in Cebu or GLGC ([Table 5](#table-5){ref-type="table"}). In humans, *PAX6* has been associated with insulin production ([@ref-2]). Currently, there is little known about *PAX6* and its potential association with lipid or cardiovascular phenotypes.
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###### Top genes (FDR \<0.1) in Yoruba and Cebu found using PrediXcan.

All results are for the TRIG phenotype. Results from both populations and the Global Lipids Genetic Consortium (GLGC) are shown. Six associations discovered in Cebu replicated in the GLGC.
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  Chr.      Tissue    Gene name   Beta (Yoruba)   P (Yoruba)     FDR (Yoruba)   Beta (Cebu)   P (Cebu)        FDR (Cebu)      Beta (GLGC)   P (GLGC)
  --------- --------- ----------- --------------- -------------- -------------- ------------- --------------- --------------- ------------- ----------------
  2p23.3    THYROID   *FNDC4*     0.05            0.50           0.99           −0.24         1.0 × 10^−6^    0.037           −0.11         7.7 × 10^−83^
  11p13     ARTAORT   *PAX6*      −0.74           4.8 × 10^−7^   0.093          0.16          0.20            0.98            0             0.91
  11q23.3   ESPMCS    *BACE1*     0.22            0.33           0.99           −3.30         1.7 × 10^−15^   3.0 × 10^−10^   −0.17         7.3 × 10^−19^
  11q23.3   CLNSGM    *APOA4*     0.80            0.55           0.99           −11.6         6.5 × 10^−12^   5.9 × 10^−7^    −1.95         1.7 ×10^−39^
  11q23.3   BRNHPP    *APOA1*     0.015           0.88           0.99           0.50          3.2 × 10^−7^    0.019           0             0.31
  11q23.3   HRTLV     *SIDT2*     0.24            0.21           0.98           0.90          8.1 × 10^−7^    0.037           0.16          9.3 × 10^−29^
  11q23.3   THYROID   *SIDT2*     0.10            0.61           0.99           −0.55         1.7 × 10^−6^    0.050           −0.55         1.1 × 10^−102^
  11q23.3   WHLBLD    *BACE1*     0.00            0.99           0.99           −0.79         3.4 × 10^−6^    0.087           −0.28         4.0 × 10^−28^

Cebu gene-based association study
---------------------------------

When we applied PrediXcan to the Cebu cohort, seven genes were found significant ([Table 5](#table-5){ref-type="table"}). A few of these genes, such as *FNDC4*, *APOA1* and *APOA4*, are well-documented in lipid traits, while genes such as *SIDT2* have been previously implicated in Asians ([@ref-47]; [@ref-27]; [@ref-51]; [@ref-53]; [@ref-57]; [@ref-24]; [@ref-31]; [@ref-45]). The association of *BACE1* with TRIG was highly significant (FDR = 3.02 × 10^−10^, [Fig. 4](#fig-4){ref-type="fig"}). The predicted increase in *BACE1* expression and decrease in TRIG levels is an association not previously seen in humans, but has been observed in mice ([@ref-36]; [@ref-8]) ([Fig. 5](#fig-5){ref-type="fig"}). Additionally, *SIDT2* has a similar effect across many tissue models, indicating its potential importance in regulating TRIG levels as well ([Figs. 5](#fig-5){ref-type="fig"} and [6](#fig-6){ref-type="fig"}). Both *BACE1* and *SIDT2* have increased gene expression associated with decreased TRIG levels in most tissues and share many SNPs in most of their prediction models.

![PrediXcan results for the Cebu TRIG phenotype using gene expression models built in 44 GTEx tissues.\
(A) Manhattan plot: −log~10~ *P*-values are plotted against the respective chromosomal position of each gene across all tissues. (B) QQ plot of observed versus expected −log~10~ *P*-values for each gene across all tissues.](peerj-06-4314-g004){#fig-4}

![TRIG levels vs. predicted expression of two genes in Cebu.\
(A) *BACE1* predicted expression using the GTEx ESPMCS prediction model. (B) *SIDT2* predicted expression using the GTEx LCL prediction model.](peerj-06-4314-g005){#fig-5}

We conducted a backward elimination analysis to determine the lead gene or genes at the 11q23.3 locus. The starting model include all gene-tissue combinations in [Fig. 6](#fig-6){ref-type="fig"}, which includes all genes with [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) or a linked SNP (*r*^2^ \> 0.6) in its predictive model and \|*t*\| \> 3, where *t* is the association test statistic. The most significant gene in the final model was ESPMCS-*BACE1* (*P* = 1 × 10^−10^), with residual effects present (*P* \< 0.05) for LCL-*SIDT2*, MSCLSK-*APOA1*, TESTIS-*CEP164*, and WHLBLD-*BACE1* ([Table 6](#table-6){ref-type="table"}).

![PrediXcan results of genes with [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) or linked SNPs (*r*^2^ \> 0.6) in their predictive models across tissues.\
The size of the circle is proportional to the absolute value of the *t*-statistic in the PrediXcan association test and the color indicates the direction of effect (sign of the t-statistic, −1 or 1) multiplied by the prediction performance of the model (*R*^2^) for each gene-tissue combination. Only genes $\documentclass[12pt]{minimal}
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}{}$ \left\vert t \right\vert \gt 3$\end{document}$ are plotted for clarity.](peerj-06-4314-g006){#fig-6}
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###### Gene-tissue combinations from [Fig. 6](#fig-6){ref-type="fig"} with *P* \< 0.05 in a backwards-elimination linear model including the TRIG phenotype and predicted gene expression terms.

![](peerj-06-4314-g012)

  Tissue   Gene       Estimate   Std. Error   *t* value   *P*
  -------- ---------- ---------- ------------ ----------- ---------------
  ESPMCS   *BACE1*    −3.7       0.57         −6.4        1.7 × 10^−10^
  LCL      *SIDT2*    −0.20      0.06         −3.2        0.001
  MSCLSK   *APOA1*    1.5        0.52         2.9         0.003
  TESTIS   *CEP164*   −0.17      0.08         −2.2        0.025
  WHLBLD   *BACE1*    0.83       0.29         2.9         0.003

Comparing populations
---------------------

In a direct comparison of the significant genes obtained through PrediXcan for the Cebu and Yoruba cohorts, there is no gene that shares significance (FDR \<0.10) between populations ([Table 5](#table-5){ref-type="table"}). There was no overlap in significant genes between Yoruba and GLGC, but there was overlap in significant genes between Cebu and GLGC in *FNDC4*, *SIDT2*, *APOA4*, and *BACE1* with the same effect direction for all genes ([@ref-51]) ([Table 5](#table-5){ref-type="table"}).

Discussion
==========

Using genome-wide genotypes and lipid levels obtained in two diverse populations from Ibadan, Nigeria and Cebu, Philippines, we performed multiple genome-wide analyses with the goal of better understanding the underlying genetic architecture of cholesterol traits in both populations.

Top GWAS SNPs have been previously shown to associate with lipid traits
-----------------------------------------------------------------------

Within the Yoruba portion of our study, [rs34065661](http://www.ncbi.nlm.nih.gov/snp/?term=rs34065661) and [rs17231520](http://www.ncbi.nlm.nih.gov/snp/?term=rs17231520), SNPs close to or within *CETP*, were significant ([Fig. 1A](#fig-1){ref-type="fig"}). *CETP*, cholesteryl ester transfer protein, is a well-known lipid gene previously implicated in lipid studies in African populations ([@ref-13]; [@ref-19]). *CETP* is involved in the transfer of cholesterol from HDL to other lipoproteins, and is a common genetic target for statins and other cholesterol-lowering drugs ([@ref-10]). It also has strong association with Alzheimer's disease and other neurodegenerative diseases ([@ref-54]). Additional significant SNPs in Yoruba, [rs1065853](http://www.ncbi.nlm.nih.gov/snp/?term=rs1065853), [rs7412](http://www.ncbi.nlm.nih.gov/snp/?term=rs7412), and [rs75627662](http://www.ncbi.nlm.nih.gov/snp/?term=rs75627662), are located near or within *APOE* ([Fig. 1B](#fig-1){ref-type="fig"}). *APOE*, apolipoprotein E, is another well-known cholesterol gene previously implicated in other lipid studies ([@ref-43]; [@ref-46]; [@ref-32]; [@ref-45]; [@ref-60]). It acts as a lipid transport protein in high association with LDL receptors and is also strongly associated with neurodegenerative diseases ([@ref-38]).

The most significant SNP within the Cebu GWAS portion of our study is [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799), at *P* = 2.7 ×10^−16^. It has been previously associated with cholesterol traits in Asian populations ([@ref-31]; [@ref-45]) ([Fig. 2](#fig-2){ref-type="fig"}). *APOA5* is a well-documented gene associated with triglyceride levels ([@ref-23]). Other genes within this linkage group include *ZPR1* and *BUD13*, which have both been previously implicated with triglyceride levels in East Asians as well, possibly due to its higher minor allele frequency in those populations ([@ref-27]; [@ref-29]) ([Fig. 3](#fig-3){ref-type="fig"}).

The mechanism underlying the association of [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) with TRIG levels may include long distance regulation of *BACE1* and *SIDT2*
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In our PrediXcan analysis, *BACE1* reached significance (FDR =3.0 × 10^−10^) in both the Cebu and GLGC replication cohorts, but it was not significant in Yoruba ([Fig. 4](#fig-4){ref-type="fig"}). Currently, in humans, *BACE1* is known to increase risk of Alzheimer's disease with increased expression ([@ref-14]). While not recognized as significant in the GLGC SNP meta-analysis ([@ref-51]), our application of PrediXcan to the GLGC GWAS results verified that the *BACE1* association with TRIG is significant (*P* = 7.3 × 10^−19^) ([Table 5](#table-5){ref-type="table"}).

This gene has been studied in terms of Alzheimer's disease and weight gain in mice. In our results, we found increased predicted gene expression for *BACE1* to be associated with lower TRIG levels ([Table 5](#table-5){ref-type="table"}). For *BACE1* knockout mice, there was no significant difference in triglyceride levels versus wild-type mice, but they did have lower average body weight ([@ref-36]). Additionally, in mice, higher triglyceride levels were found to reduce *BACE1* expression in a study concerning Alzheimer's treatment ([@ref-8]). This latter result is consistent with our finding that increased *BACE1* expression is associated with lower triglyceride levels ([Fig. 5](#fig-5){ref-type="fig"}).

The SNP [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) is 571 bases upstream of the gene with which it is typically associated, *APOA5* ([Fig. 2](#fig-2){ref-type="fig"}). *APOA5* was well-predicted in only one tissue, SNTTRM, and the prediction was not driven by SNPs linked to [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799). Thus, *APOA5* may not affect TRIG levels through the mechanism of variation in gene expression regulation. Even though [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) is located 493kb downstream of *BACE1*, it has the largest effect size, i.e., it is the driver SNP, in the predictive model for *BACE1* in ESPMCS. SNPs closer to *BACE1* are not linked to [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) ([Fig. 2](#fig-2){ref-type="fig"}). The similar effects and significance of *BACE1* in mouse studies, the Cebu cohort analysis, and GLGC PrediXcan results indicate the increased expression of *BACE1* is associated with decreased TRIG levels and that variation in the regulation of *BACE1* may contribute to differences in TRIG levels.

Another significant gene in our gene-based association study of TRIG in Cebu is *SIDT2*, which is 386 kb downstream of [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799). Here, the effects of many SNPs, including some linked to [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799), combine in the prediction model for *SIDT2* gene expression, with no dominant driver SNP, as demonstrated by the lack of discernible clusters in the plot of TRIG levels versus predicted expression ([Fig. 5](#fig-5){ref-type="fig"}). Additionally, *SIDT2* exhibits more consistent effect sizes over more tissues than *BACE1* ([Fig. 6](#fig-6){ref-type="fig"}), in which predicted expression is associated with higher TRIG levels ([Fig. 5](#fig-5){ref-type="fig"}).

*SIDT2*, along with others nearby on the same chromosome, has been previously implicated in East Asian GWAS ([@ref-24]). In our results, we found increased predicted gene expression for *SIDT2* to be associated with lower TRIG levels in most models. *SIDT2* has been associated with glucose and lipid metabolism in mice, as *SIDT2* knockout mice have significantly higher serum levels of TRIG than wild-type mice ([@ref-22]). Since increased gene expression is associated with lower TRIG levels in our cohort for a majority of models, our models concur with the association present within mice. Significance of *SIDT2* for TRIG in LCL was also replicated in GLGC at *P* = 1.1 ×10^−102^ ([Table 5](#table-5){ref-type="table"}). The similar effects and significance of *SIDT2* in knockout mice studies, the Cebu cohort analysis, and GLGC PrediXcan results indicate that increased expression of *SIDT2* is associated with decreased TRIG levels. Therefore, variation in the regulation of *SIDT2* may contribute to differences in TRIG levels.

In an attempt to disentangle the multiple genes associated with TRIG at the 11q23.3 locus, we performed backwards elimination modeling. This analysis showed that *BACE1* has the strongest effect at the locus, with *SIDT2*, *APOA1*, and *CEP164* contributing smaller effects.

[rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) has a greater impact in East Asian populations
---------------------------------------------------------------------------------------------------------

The significant SNPs in the GWAS portion of our study have been previously associated with lipid traits, but these prior studies did not conduct a robust gene-based association modeling ([@ref-26]; [@ref-13]; [@ref-43]; [@ref-53]). In our PrediXcan analysis, we implicated a new gene (*PAX6*) in Yoruba and additional genes at the chromosome 11 locus in Cebu, including genes with predictive SNPs located hundreds of thousands of base pairs away from their transcription start sites.

[rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) in particular is a significant SNP in cholesterol GWAS of East Asians ([@ref-47]; [@ref-53]; [@ref-29]; [@ref-31]; [@ref-45]), with its minor allele frequency as high as 0.37 in the 1000 Genomes Japanese (JPT) population, and it is also the top SNP, with a minor allele frequency of 0.245, in our own TRIG GWAS analysis for Cebu ([Table 3](#table-3){ref-type="table"}). [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) has a low minor frequency in European and African populations, indicating that even if effects are similar, it has a lower allelic impact in European and African ancestry populations ([Fig. 3](#fig-3){ref-type="fig"}). In Asian populations, therefore, [rs662799](http://www.ncbi.nlm.nih.gov/snp/?term=rs662799) has a more significant genetic impact ([@ref-11]) due to its higher MAF, causing the difference in phenotypic effects. This demonstrates how prediction models may vary in utility across populations.

Conclusions
===========

In this study, we use a transcriptome-informed approach to implicate new genes in lipid traits. Limitations arose from the small sample sizes in desired populations and the lack of population-specific transcriptome prediction models. Other lipid trait GWAS, such as the GLGC, included over 180,000 individuals of European ancestry ([@ref-51]), while each population in this study had less than 2,000 individuals. Current GTEx models are based on an 85% European-American and 15% African-American population, which cannot be fully extrapolated to diverse populations. While Yoruba in Ibadan, Nigeria is a HapMap population, and specific reference panels exist for African populations, there is a lack of publicly available data for southeast Asian and Pacific Islander populations, which is an issue due to the rarer variants in more isolated island populations ([@ref-30]). For example, the reference panel used for imputation, 1000 Genomes Phase 3, contains only Vietnamese, Chinese, and Japanese genotypes for East Asian populations ([@ref-6]). Without data collection and proper models for non-European populations, there is less potential for accurate implementation of precision medicine. To fully characterize the impact of genetic variation between populations, larger studies in non-European populations are needed.
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